Shanghai Huaota Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Huaota Biopharmaceutical Co., Ltd., explained in plain language.
-
New Two-Target drug enters human testing for painful skin condition
Disease control Recruiting nowThis early-stage study is testing a new drug called HB0043 in adults with moderate to severe hidradenitis suppurativa (HS), a painful chronic skin condition. The main goal is to check the drug's safety and see if it can reduce the number of painful skin lesions. Participants will…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
First human test for experimental drug begins
Knowledge-focused Recruiting nowThis is an early safety study testing a new drug called HB0056 for the first time in healthy people. Researchers will give single doses to 46 healthy adults to check for side effects and see how the body processes the drug. The main goal is to determine if HB0056 is safe enough t…
Phase: PHASE1 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC